The Prescription of Drug Ontology 2.0 (PDRO): More Than the Sum of Its Parts
While drugs and related products have profoundly changed the lives of people around the world, ongoing challenges remain, including inappropriate use of a drug product. Inappropriate uses can be explained in part by ambiguous or incomplete information, for example, missing reasons for treatments, am...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/778fbcb3e5d4410c8592f13a3b61123f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:778fbcb3e5d4410c8592f13a3b61123f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:778fbcb3e5d4410c8592f13a3b61123f2021-11-25T17:50:24ZThe Prescription of Drug Ontology 2.0 (PDRO): More Than the Sum of Its Parts10.3390/ijerph1822120251660-46011661-7827https://doaj.org/article/778fbcb3e5d4410c8592f13a3b61123f2021-11-01T00:00:00Zhttps://www.mdpi.com/1660-4601/18/22/12025https://doaj.org/toc/1661-7827https://doaj.org/toc/1660-4601While drugs and related products have profoundly changed the lives of people around the world, ongoing challenges remain, including inappropriate use of a drug product. Inappropriate uses can be explained in part by ambiguous or incomplete information, for example, missing reasons for treatments, ambiguous information on how to take a medication, or lack of information on medication-related events outside the health care system. In order to fully assess the situation, data from multiple systems (electronic medical records, pharmacy and radiology information systems, laboratory management systems, etc.) from multiple organizations (outpatient clinics, hospitals, long-term care facilities, laboratories, pharmacies, registries, governments) on a large geographical scale is needed. Formal knowledge models like ontologies can help address such an information integration challenge. Existing approaches like the Observational Medical Outcomes Partnership are discussed and contrasted with the use of ontologies and systems using them for data integration. The PRescription Drug Ontology 2.0 (PDRO 2.0) is then presented and entities that are paramount in addressing this problematic are described. Finally, the benefits of using PDRO are discussed through a series of exemplar situation.Jean-François EthierFrançois GoyerPaul FabryAdrien BartonMDPI AGarticledrug ontologydrug prescriptionoptimization of prescriptionmedication managementontology developmentdata annotationMedicineRENInternational Journal of Environmental Research and Public Health, Vol 18, Iss 12025, p 12025 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
drug ontology drug prescription optimization of prescription medication management ontology development data annotation Medicine R |
spellingShingle |
drug ontology drug prescription optimization of prescription medication management ontology development data annotation Medicine R Jean-François Ethier François Goyer Paul Fabry Adrien Barton The Prescription of Drug Ontology 2.0 (PDRO): More Than the Sum of Its Parts |
description |
While drugs and related products have profoundly changed the lives of people around the world, ongoing challenges remain, including inappropriate use of a drug product. Inappropriate uses can be explained in part by ambiguous or incomplete information, for example, missing reasons for treatments, ambiguous information on how to take a medication, or lack of information on medication-related events outside the health care system. In order to fully assess the situation, data from multiple systems (electronic medical records, pharmacy and radiology information systems, laboratory management systems, etc.) from multiple organizations (outpatient clinics, hospitals, long-term care facilities, laboratories, pharmacies, registries, governments) on a large geographical scale is needed. Formal knowledge models like ontologies can help address such an information integration challenge. Existing approaches like the Observational Medical Outcomes Partnership are discussed and contrasted with the use of ontologies and systems using them for data integration. The PRescription Drug Ontology 2.0 (PDRO 2.0) is then presented and entities that are paramount in addressing this problematic are described. Finally, the benefits of using PDRO are discussed through a series of exemplar situation. |
format |
article |
author |
Jean-François Ethier François Goyer Paul Fabry Adrien Barton |
author_facet |
Jean-François Ethier François Goyer Paul Fabry Adrien Barton |
author_sort |
Jean-François Ethier |
title |
The Prescription of Drug Ontology 2.0 (PDRO): More Than the Sum of Its Parts |
title_short |
The Prescription of Drug Ontology 2.0 (PDRO): More Than the Sum of Its Parts |
title_full |
The Prescription of Drug Ontology 2.0 (PDRO): More Than the Sum of Its Parts |
title_fullStr |
The Prescription of Drug Ontology 2.0 (PDRO): More Than the Sum of Its Parts |
title_full_unstemmed |
The Prescription of Drug Ontology 2.0 (PDRO): More Than the Sum of Its Parts |
title_sort |
prescription of drug ontology 2.0 (pdro): more than the sum of its parts |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/778fbcb3e5d4410c8592f13a3b61123f |
work_keys_str_mv |
AT jeanfrancoisethier theprescriptionofdrugontology20pdromorethanthesumofitsparts AT francoisgoyer theprescriptionofdrugontology20pdromorethanthesumofitsparts AT paulfabry theprescriptionofdrugontology20pdromorethanthesumofitsparts AT adrienbarton theprescriptionofdrugontology20pdromorethanthesumofitsparts AT jeanfrancoisethier prescriptionofdrugontology20pdromorethanthesumofitsparts AT francoisgoyer prescriptionofdrugontology20pdromorethanthesumofitsparts AT paulfabry prescriptionofdrugontology20pdromorethanthesumofitsparts AT adrienbarton prescriptionofdrugontology20pdromorethanthesumofitsparts |
_version_ |
1718411928529797120 |